Search Site

Zilico Limited

Zilico News

Keep up to date with the latest news and press releases from Zilico.

  • The Changing Face of Colposcopy

    Jun '16 29

    Discussion around how the introduction of HPV primary testing, vaccination and the use of adjunctive technologies are changing the face of colposcopy was a key focus at this year’s Royal College of Obstetricians and Gynaecologists (RCOG) World Congress.
    more details ]
  • Zilico Ltd selected for the Inaugural TechEmerge Health Innovation Summit

    Jun '16 10

    Zilico Ltd has been selected to participate in the inaugural TechEmerge program, an initiative of IFC, a member of the World Bank Group. TechEmerge is a first-of-its-kind matchmaking program that connects technology companies from around the world with corporations in emerging markets, to conduct pilot projects and foster commercial partnerships. The inaugural phase of the program is focused on the healthcare sector in India.
    more details ]
  • ZedScan™ delivers significant increase in HG CIN detection rates across all high risk HPV positive women

    Apr '16 12

    A review into the management of more than 800 women referred to an NHS colposcopy clinic who were positive for high risk HPV (hrHPV) has revealed a substantial increase in detection of high grade cervical intraepithelial neoplasia (HG CIN) following the adoption of ZedScan into routine use. 
    more details ]
  • Zilico Ltd selected for the 2016 Medical Device Hotlist

    Mar '16 18

    Zilico Ltd has been selected for inclusion in the 2016 Medical Device SME Hotlist , published by the Council of European BioRegions asbl (CEBR), following a nomination by CEBR member TRUSTECH .
    more details ]
  • Professor Tidy guest lecturer at South Asian cancer conference

    Mar '16 1

    Zilico Ltd’s clinical founder, Professor John Tidy, has been invited by the Delhi State Cancer Institutes to participate in an international cancer conference in India.
    more details ]
  • 1,000 patient case study published for ZedScan™

    Jan '16 22

    Zilico Ltd has published a 1,000 patient case study for its cervical cancer diagnostic system, ZedScan ™ , to coincide with the start of Cervical Cancer Prevention Week (24-30 January).   The patient review in to the routine use of ZedScan as an adjunct to colposcopy has revealed that the technology significantly increases the rate of detection of high grade cervical intraepithelial neoplasia (HG CIN).
    more details ]
  • Zilico appoints new Commercial Director

    Jan '16 12

    Zilico Ltd has strengthened its team with the appointment of a new Commercial Director. Andrew Saipe, who has 25 years’ experience in medical sales, joins Zilico from Purple Surgical, where he looked after many of the International markets for eight years. Prior to this, Andrew was a sales manager with Medtronic (Covdien) for 5 years.
    more details ]
  • Central Manchester NHS Trust adopts ZedScan™

    Dec '15 10

    DP Medical Systems Ltd has secured a deal with Central Manchester University Hospitals NHS Foundation Trust (CMFT) to adopt ZedScan™ as part of its cervical cancer care pathway. The Trust has introduced ZedScan into the Gynaecology department at Saint Mary’s Hospital, Manchester - a centre of excellence in the field of gynaecological oncology, uro-gynaecology and reproductive medicine. 
    more details ]
  • Better patient outcomes and health economics with ZedScan

    Nov '15 3

    ZedScan, a cervical diagnostic system developed by UK company Zilico Ltd, is currently being adopted by healthcare systems across the globe and will be exhibited at MEDICA 2015. Zilico Ltd will showcase ZedScan as an exhibitor on the Great Britain and Northern Ireland Pavilion (Hall 16 Stand G18-7).
    more details ]
  • Zilico Ltd appoints new Non Executive Director

    Oct '15 21

    Zilico Ltd has appointed Steven Couldwell as a non-executive director to its Board of Directors.  Mr Couldwell is currently Chief Operating Officer and Head of Global Biosurgery at multinational pharmaceutical company, Sanofi Corporation.
    more details ]